Concepedia

Publication | Closed Access

PCN64 Cost-Effectiveness of Pembrolizumab (KEYTRUDA®) in Combination with Chemotherapy for First-LINE Treatment of Metastatic Squamous NON-SMALL Cell LUNG Cancer (NSCLC) in France

DOI

17

Citations

0

References

2020

Year

C. Chouaïd, L. Bensimon, J. Tardu, A. Millier, R. Insinga, Ashutosh Rai, L. Lévy-Bachelot, Pierre Lévy
Value in Health

No additional data available for this publication yet. Check back later!